Rioteph 1mg (Riociguat Tablet) 1mg

Rioteph 1mg (Riociguat 1mg) is a prescription tablet used to treat pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. This medication helps improve exercise capacity and reduce symptoms. Store at ambient temperature, away from moisture.

Strength

1mg

Pack Size

100s

Storage

Ambient

Manufacturer / TM Owner

CIPLA LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rioteph 1mg is prescribed to manage pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). It works by relaxing blood vessels in the lungs to improve blood flow. This medication is often used when other treatments have not been effective. Always follow your doctor’s guidance for use.

Side Effects

Rioteph 1mg may help reduce breathlessness and fatigue, improving daily activity levels. Some users report better endurance during physical tasks. Effects vary by individual and may take time to become noticeable. Regular monitoring by a healthcare provider is recommended.

Precautions & Warnings

Rioteph 1mg should be taken exactly as prescribed by your doctor. Do not crush, split, or chew the tablets. Keep the medication in its original packaging to protect it from moisture. Inform your doctor about all other medications you are taking before starting Rioteph 1mg.

Avoid Interactions

Rioteph 1mg can interact with certain medications, including nitrates, PDE-5 inhibitors, and strong CYP3A4 inhibitors. Avoid grapefruit products while taking this medication, as they may increase side effects. Alcohol use should be discussed with your doctor before starting treatment.

Frequently Asked Questions

Rioteph 1mg is used to treat pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension by improving blood flow in the lungs.

Store Rioteph 1mg at ambient temperature, away from moisture and direct sunlight, in its original packaging.

Consult your doctor before combining Rioteph 1mg with other drugs, as it may interact with certain medications like nitrates or PDE-5 inhibitors.

Common side effects may include headache, dizziness, or upset stomach. Report persistent effects to your healthcare provider.

Rioteph 1mg is not recommended during pregnancy unless clearly needed. Discuss risks and benefits with your doctor.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.